Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.
Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Sanmina (Nasdaq: SANM ) , whose recent revenue and earnings are plotted below.
Top Supermarket Stocks To Own Right Now: Pampa Energia S.A.(PAM)
Pampa Energia S.A., through its subsidiaries, engages in the generation, transmission, and distribution of electricity in Argentina. It has an installed hydro electricity generation capacity of approximately 2,217 megawatts. The company also joint-controls the operation and maintenance of the high-tension transmission network covering 10,613 kilometers (km) of own lines, as well as 6,110 km of high-tension lines belonging to Empresa de Transporte de Energ� El�tricapor Distribuci� Troncal de la Provincia de Buenos Aires Sociedad An�ima Transba S.A. It distributes electricity to approximately 3.5 million residential, commercial, and industrial customers. The company was formerly known as Pampa Holding S.A. and changed its name to Pampa Energia S.A. in September 2008. Pampa Energia S.A. was incorporated in 1945 and is headquartered in Buenos Aires, Argentina.
Advisors' Opinion:- [By Garrett Cook]
Utilities shares rose 0.26 percent in today’s trading. Top gainers in the sector included Pampa Energia SA (NYSE: PAM), up 2 percent, and New Jersey Resources (NYSE: NJR), up 1.9 percent.
- [By Garrett Cook]
Utilities shares fell around 0.30 percent in trading on Friday. Top losers in the sector included Pampa Energia SA (NYSE: PAM), revesed loses and is currently up 1.75 percent, and Korea Electric Power (NYSE: KEP), off 3.16 percent.
- [By Eddie Staley]
Utilities shares rose 0.26 percent in today’s trading. Top gainers in the sector included Pampa Energia SA (NYSE: PAM), up 2.88 percent, and New Jersey Resources (NYSE: NJR), up 2.39 percent.
Top Net Payout Yield Companies To Buy Right Now: Lloyds Banking Group PLC (LYG)
Lloyds Banking Group plc, incorporated on October 21, 1985, is a holding company. The Company is a financial services group providing a range of banking and financial services, primarily in the United Kingdom, to personal and corporate customers. The Company operates in four segments: Retail, Commercial Banking, Wealth, Asset Finance and International and Insurance. Retail provides banking, mortgages and other financial services to personal customers in the United Kingdom. Commercial Banking provides banking and related services to business clients, from small businesses to large corporate. Wealth, Asset Finance and International provides private banking and asset management and asset finance in the United Kingdom and overseas and operates the Company�� international retail businesses. Insurance provides long term savings, protection and investment products in the United Kingdom and Europe and provides general insurance to personal customers in the United Kingdom.
Retail
The Retail division operates the retail bank in the United Kingdom and is a provider of current accounts, savings, personal loans, credit cards and mortgages. This includes a range of current accounts including packaged accounts and basic banking accounts. It is also the provider of personal loans in the United Kingdom, as well as being the United Kingdom�� credit card issuer. Retail is the private sector savings provider in the United Kingdom. It is also a general insurance and bancassurance distributor, offering a range of long-term savings, investment and general insurance products.
Commercial Banking
The Commercial Banking division supports the Company�� business clients from small businesses to corporate. Commercial Banking provides support to corporate clients through the provision of core banking products, such as lending, deposits and transaction banking services whilst also offering clients expertise in capital markets (private placements, bonds and syndicated loans), ! financial markets (foreign exchange, interest rate management, money market and credit) and private equity.
Wealth, Asset Finance and International
Wealth, Asset Finance and International consists of the Company�� the United Kingdom and international wealth businesses, the Company�� the United Kingdom and international asset finance and online deposit businesses along with its international retail businesses. The Wealth business consists of private banking and asset management. Wealth�� private banking operations cater to the range of wealth clients from affluent to Ultra High Net Worth within the United Kingdom, Channel Islands and Isle of Man, and internationally. Asset Finance consists of a number of leasing and speciality lending businesses in the United Kingdom, including Lex Autolease and Black Horse Motor and Personal Finance along with its leasing and specialty lending businesses in Australia and its European online deposit business. The international business comprises its non-core banking business outside the United Kingdom, with the exception of corporate business written through the Commercial Banking division. This primarily consists of Ireland, Retail Europe and Asia.
Insurance
The Insurance division provides long-term savings, protection and investment products and general insurance products to customers in the United Kingdom and Europe. The United Kingdom Life, Pensions and Investments business provides long-term savings, protection and investment products distributed through the bancassurance, intermediary and direct channels of the Lloyds TSB, Halifax, Bank of Scotland and Scottish Widows brands. The European Life, Pensions and Investments business distributes products primarily in the German market under the Heidelberger Leben and Clerical Medical brands. The General Insurance business is a distributor of home insurance in the United Kingdom, with products sold through the branch network, direct channels and strategic corporate! partners! . It operates primarily under the Lloyds TSB, Halifax and Bank of Scotland brands.
Advisors' Opinion:- [By David O��ara]
The sector
All three have had a great 12 months. In the last year, shares in�Barclays� (LSE: BARC ) (NYSE: BCS ) are up 46.2%.�Lloyds Banking Group� (LSE: LLOY ) (NYSE: LYG ) is up 80.7%, and�Royal Bank of Scotland� (LSE: RBS ) is ahead 22.3%. - [By Tony Reading]
LONDON --�A few weeks ago, I asked�"When will the Government Sell Shares in Lloyds and RBS?", suggesting that David Cameron would do something before the next general election in May 2015. Since then, managers at both�Lloyds� (LSE: LLOY ) (NYSE: LYG ) �and�RBS� (LSE: RBS ) (NYSE: RBS ) �have made positive noises about being ready for privatization in that time-scale.
Top Net Payout Yield Companies To Buy Right Now: Dynavax Technologies Corporation(DVAX)
Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious diseases. The company's lead product candidate includes HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine designed to provide protection with fewer doses than current licensed vaccines. It also develops Universal Flu vaccine, a Phase 1b clinical trial vaccine for influenza prevention; SD-101, a Phase Ib clinical trial hepatitis C therapy; DV-601, a Phase Ib clinical trial hepatitis B therapy; AZD1419, a preclinical asthma therapy; and DV1179, a Phase 1 trial autoimmune and inflammatory disease therapy. Dynavax Technologies Corporation has strategic alliance with GlaxoSmithKline plc to discover, develop, and commercialize DV1179 and other endosomal toll-like receptor inhibitors for diseases, such as lupus, psoriasis, and rheumatoid arthritis; and develop a TLR8 inhibitor for the treatment of multiple autoimmune and i nflammatory diseases, as well as has research and license agreement with AstraZeneca to discover and develop TLR9 agonist-based therapies for the treatment of asthma and chronic obstructive pulmonary disease. The company was founded in 1996 and is based in Berkeley, California.
Advisors' Opinion:- [By Selena Maranjian]
Finally, Westfield's biggest closed positions included Ralcorp and Vertex Pharmaceuticals. Other closed positions of interest include Dynavax (NASDAQ: DVAX ) and JDS Uniphase (NASDAQ: JDSU ) . Dynavax shares fell sharply upon an FDA rejection of its hepatitis B vaccine Heplisav. The FDA left open the possibility of a more limited approval, but Dynavax now has more work to do, and it's burning cash while its revenue has been shrinking. Fortunately, it does seem to have have ample cash�to keep it afloat for a few years. Investors are right to worry about share dilution, too. Dynavax has partnered with GlaxoSmithKline�on Heplisav, and its new CEO hails from GlaxoSmithKline as well.
- [By Keith Speights]
Dynavax (NASDAQ: DVAX ) is a good case in point. The company's Heplisav hepatitis B vaccine looked good in clinical trials when compared to the leading vaccine on the market. Dynavax thought that the safety profile for Heplisav also compared favorably. The Food and Drug Administration even told the company that it could expand its Biologic License Application, or BLA, to include a wider age range of adults than originally planned.
Top Net Payout Yield Companies To Buy Right Now: Alexza Pharmaceuticals Inc.(ALXA)
Alexza Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. Its product candidates are based on a proprietary technology, the Staccato system, which vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The company?s lead product candidate includes ADASUVE (Staccato loxapine) for the acute treatment of agitation in adults with schizophrenia or bipolar disorder. Its other product candidates under development comprise AZ-007 (Staccato zaleplon), which has completed Phase I clinical trials for the treatment of insomnia; and Staccato nicotine that is in pre-Phase 1 clinical trials to help smokers quit by addressing both the chemical and behavioral components of nicotine addiction by delivering nicotine replacement through inhalation. The company was f ormerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Edison Investment Research]
Alexza's (ALXA) US marketing deal with Teva (TEVA) for Adasuve (orally-inhaled loxapine) enhances the product's US sales prospects given Teva's expertise in the psychiatric and hospital markets. Adasuve is a potentially disruptive new product for acute agitation in schizophrenia or bipolar disorder, given its advantages over existing options (injection/oral/buccal). The investment case is shifting from a development/regulatory play to one of commercial execution by Adasuve's licensees, Teva in the US and Ferrer in Europe.
Top Net Payout Yield Companies To Buy Right Now: FX Energy Inc (FXEN)
FX Energy, Inc. is an independent oil and gas exploration and production company with production, appraisal, and exploration activities in Poland. The Company operates within two segments of the oil and gas industry: the exploration and production (E&P) segment in Poland and the United States, and the oilfield services segment in the United States. The Company also has oil production, oilfield service activities, and a shale acreage position in the United States. During the year ended December 31, 2011, its oil and gas production was 4.4 billion cubic feet of natural gas (12.0 million cubic feet equivalent per day). The Company concentrates its exploration operations in Poland primarily on the Rotliegend sandstones of the Permian Basin. The Company has identified a core area consisting of approximately 852,000 gross acres surrounding PGNiG�� producing Radlin field.
Activities and Presence in Poland
The Company conducts its activities in Poland in project areas, including Fences, Blocks 287, 246, and 229 near the Fences concession, Warsaw South, Kutno, Northwest, and Edge. In the Fences during 2011, it completed the Lisewo-1 well as a commercial well and drilled the Plawce-2 well in a tight sand area. In its other concessions it drilled the Machnatka-2 well, a noncommercial Zechstein/Carboniferous test, in the Warsaw South concession, and started drilling the Kutno-2 well, a deep Rotliegend test, in the Kutno concession. The Fences concession area encompasses 852,000 gross acres (3,450 square kilometers) in western Poland�� Permian Basin. The Fences concession area encompasses 852,000 gross acres (3,450 square kilometers) in western Poland�� Permian Basin. The Company has drilled 11 conventional wells targeting Rotliegend structures through the date of this filing. Eight of these wells are commercial. The Company is produce from four of these eight wells.
The Block 287 concession area is 12,000 acres (50 square kilometers) located approximately 25 miles so! uth of the Fences concession area. The Company owns 100% of the exploration rights. As of December 31, 2011, it has reentered only the Grabowka-12 well. During 2011, it produced at an average daily rate of approximately 0.2 million cubic feet of natural gas per day. The Company has a 100% interest in a concession south of its Fences project area covering approximately 241,000 acres (975 square kilometers). The Company hold a 51% interest in a total of 874,000 acres (3,538 square kilometers.) in east-central Poland. During 2011, it entered into a farmout agreement with PGNiG under which it earned a 49% interest in the entire Warsaw South concession in return for paying certain seismic and drilling costs. It subsequently drilled the Machnatka-2 well to test Zechstein and Carboniferous potential in the western part of the concession area.
The Company holds a 100% interest in 706,000 acres (2,856 square kilometers). The area encompasses a Rotliegend structure (Kutno) with projected four-way dip closure. It started drilling the Kutno-2 well during 2011. It hold concessions on 828,000 acres (3,351 square kilometers) in west-central Poland, in Poland�� Permian Basin directly north of PGNiG�� BMB and MLG oil and gas fields. The Company has a 100% interest in four concessions in north-central Poland covering approximately 881,000 acres (3,567 square kilometers). As of December 31, 2011, it held oil and gas exploration rights in Poland in separately designated project areas encompassing approximately 4.6 million gross acres. The Company is the operator in all areas, except its 852,000 gross-acre core Fences project area, in which it hold a 49% interest in approximately 807,000 acres and a 24.5% interest in the remaining 45,000 acres.
U.S. Activities and Presence
The operations consist of shallow, oil-producing wells in the Southwest Cut Bank Sand Unit (SWCBSU), of Montana. Its oil wells produce approximately 155 barrels of oil per day, net to its interest. From its fie! ld office! in Montana, the Company also provides oilfield services. The Company produces oil from approximately 10,732 gross (10,418 net) acres in Montana and 400 gross (128 net) acres in Nevada. In 2011, the Company entered into a joint venture with two other companies, American Eagle Energy, Inc., and Big Sky Operating LLC, in which it pooled our approximately 10,000 net acres in our SWCBSU with their approximately 65,000 net acres, the Americana leases, along with a farmout agreement that provides the group with an ability to earn an interest in an additional 7,000 acres covered by the Somont leases. During 2011, it drilled three vertical wells on joint venture acreage to obtain log and core data. The Company also drilled a 3,600-foot lateral from one of these three wells, the Anderson 14-29, and carried out a multistage fracture. The Company is testing oil potential in the Anderson 14-29 well. The Company has a one-third working interest in all formations below the Cut Bank in its SWCBSU.
Advisors' Opinion:- [By Roberto Pedone]
FX Energy (FXEN) is an independent oil and gas exploration and production company with principal production, reserves and exploration in Poland and oil production, oilfield service and exploration activities in the U.S. This stock closed up 5.7% to $3.69 in Thursday's trading session.
Thursday's Range: $3.34-$3.71
52-Week Range: $2.48-$8.78
Thursday's Volume: 524,000
Three-Month Average Volume: 672,515From a technical perspective, FXEN bounced notably higher here right above some near-term support at $3.31 and back above its 50-day moving average of $3.66 with decent upside volume. This move is quickly pushing shares of FXEN within range of triggering a near-term breakout trade. That trade will hit if FXEN manages to take out some near-term overhead resistance levels at its 200-day moving average of $3.89 to more resistance at $3.98.
Traders should now look for long-biased trades in FXEN as long as it's trending above support at $3.31 and then once it sustains a move or close above those breakout levels with volume that hits near or above 672,515 shares. If that breakout triggers soon, then FXEN will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.76. Any high-volume move above those levels will then put its recent high at $5 into range for shares of FXEN.
- [By James E. Brumley]
I hate to be the one to say I told you so, but, I told you so. Within the past week I suggested both FX Energy, Inc. (NASDAQ:FXEN) and MeetMe Inc. (NYSEMKT:MEET) were on the verge of breakouts, and sure enough, both are making good on that promise today; FXEN is up 5%, and MEET shares are higher by nearly 13%. Granted, the market's bullish tide is helping... a little. But, with both of these stocks outpacing the market's gain today, odds are that we would have seen these breakout moves anyway.
- [By Roberto Pedone]
Another energy player that's starting to trend within range of triggering a major breakout trade is FX Energy (FXEN), which is an independent oil and gas exploration and production company with principal production, reserves and exploration in Poland and oil production, oilfield service and exploration activities in the U.S. This stock is off to a slow start in 2013, with shares off by 14%.
If you take a look at the chart for FX Energy, you'll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months and change, with shares moving between $2.93 on the downside and $3.98 on the upside. Shares of FXEN are now starting to bounce higher off its 50-day moving average of $3.36 share, and it's quickly moving within range of triggering a major breakout trade above the upper-end of its recent range.
Traders should now look for long-biased trades in FXEN if it manages to break out above some key near-term overhead resistance levels at $3.62 to $3.71 a share and then above more resistance at $3.98 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action 377,632 shares. If that breakout hits soon, then FXEN will set up to re-test or possibly take out its next major overhead resistance levels at $4.50 to $4.76 a share. Any high-volume move above those levels will then give FXEN a chance to tag or trend above $5 a share.
Traders can look to buy FXEN off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.15 or $2.93 a share. One could also buy FXEN off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By James E. Brumley]
If it seems like you've heard the market buzzing about FX Energy, Inc. (NASDAQ:FXEN) quite a bit of late, you're not crazy - it's been in the spotlight a little more than usual over the past few weeks. And for good reason. FXEN shares are about to explode higher. All they need is the right nudge. More on that in a second.
No comments:
Post a Comment